Post on 14-Mar-2021
Pacific Hospital Supply Co., Ltd 2Q2016 Company Report
2
Our Milestone
1977 PAHSCO formed with a stock Capital of NT$ 1 Million
1980 Started the production & trading of central medical gas equipment
2001 Tong Lo Factories received ISO9001 & CE Certification
2002 Tong Lo (F0) received GMP Certification
2004 PAHSCO became a public listed company in the stock market
2005 Tong Lo (F0’) formed to expand the production of sterilize medical product
2006 The automatic warehousing system was officially implemented in August
1987
2010 Obtained 11,997m2 of production capacity and expanded Tong Lo (F3)
2009 Tong Lo (F1) constructed on November
2008
2011
Issued series of secured domestic convertible bonds & obtained 7,085 m2 of land
Implemented Oracle ERP systems
2012 Implemented BPM system
PAHSCO was Ranked Top 5% for Corporate Governance in 2014 & 2015 & has been awarded with Best Rankings for Information Transparency and Disclosure for 7 consecutive years since 2008.
2013
Tong Lo (F2) constructed & expanded the production of gas piping products
2014
Established a subsidiary company - Pacific Precision Technology Co., Ltd.
2015
Established mold department in the subsidiary company
Started to build a New Factory in the Tong Lo Science Park in January
Common Wealth Magazine (May,2016 edition)
Ranked PAHSCO • No. 1071 in Top 2000 Enterprise
• No. 48 Most Profitable Manufacturer • No. 10 in Precision Instrument Industry
• No. 325 for Sales Growth • No. 405 for After Tax Profit
Company News
Taichung Office
4 Factories in the Tong-Lo Industrial Park
Taipei Headquarter
Our Location
Miaoli
Taiwan
Future New Factory in the Tong-Lo Science Park
5
Land Area Floor Area Number of Workers
25000 m²
Factories 33000 m² (Full capacity of 1.8B TWD Sales)
AS/RS 1650 m² (2400 storage spaces)
Dorm 2000 m² (150 people capacity)
--------------------- Total of 36650 m²
730 people
*As of 2016Q2
Current Factories
6
New Factory
Land Buildings Capacity
49000 m²
Factory 44100 m² AS/RS 4500m²
(8100 storage spaces)
Dorm 6000m² (300 people capacity)
--------------------- Total of 54600 m²
12 Sterilizer 4.3B TWD sales
With full capacity
*Calculation base: Each sterilizes 30M TWD
per month
Our Certificate
-
50
100
150
200
250
300
350
400
450
Middle Eastand Africa
OtherEurope Asia Pacific
WesternEurope America
Global
8 14
72 91
155
340
11 16
92 99
187
405
9.8% 5.7%
8.4% 2.6%
6.6%
8
Introduction to Medical Product Industry and Future
Global Market for Medical Device and Equipment:
2012-2017 CAGR 6%
Source: BMI(2014); IEK(2014)
Market size in 2012 and 2017(e)
Unit:Billion (USD)
CAGR 6.0%
9
Introduction to Medical Product Industry and Future
Global Medical Product Market Share
U.S. 39.3%
Japan 9.1%
Germany 7.9%
China 5.5%
France 4.4%
Others 33.7%
2014 USD 340 B
Source: BMI Espicom(2015); IEK(2015)
Estimated percentage by Country
U.S. 39.9%
Japan 8.8%
Germany 7.6%
China 6.0%
France 4.2%
Others 33.6%
2015 (e) USD 357 B
10
Introduction to Medical Product Industry and Future
Global Medical Product Market Share
Estimated percentage by Category
Diagnostic Imaging Product 25.2%
Medical Disposal Devices 15.5%
Assistive Device 12.5%
Orthopodic and
Implantable Product 11.9%
Orthodontic Product
6.8%
Others 28.0%
2015 USD 357 B
Source: BMI(2015); IEK(2015)
Diagnostic Imaging Product 25.2%
Medical Disposal Devices 15.5%
Assistive Device 12.5%
Orthopodic and
Implantable Product 11.8%
Orthodontic Product
6.9%
Others 28.0%
2014 USD 340 B
11 Source: Frost & Sullivan, 2010
Unit: Billion(USD)
5.94
6.53
8.9
12.47
14.25
18.4
20.48
21.07
23.45
24.34
37.1
48.08
55.8
0 10 20 30 40 50 60
Cosmetic Surgery & Lifestyle Products
Neurology & Neuromuscular Devices
Intravenous & Infusion Devices
Urology & Gynecology Devices
Ophthalmic & Optical Devices
General Surgical Therapeutic Devices
Single Use Surgical & Disposables
Minimally Invasive Surgical Devices
Wound Care and Biomaterials
Others
Orthopedic and Prosthetic Devices
Anesthetic and Respiratory Devices
Cardiology and Thoracic Surgery
Introduction to Medical Product Industry and Future
12
Market of Aging Population
Due to global low birth rate, the population
structure is aging at a fast rate. % of health
expenditure increased as people aged.
Age % of health expenditure
<25 3.4%
25~34 5.4%
35~44 6.5%
45~54 6.8%
55~64 8.8%
>65 13.4%
*Source: Franklin Templeton(2016); Council for Economic Panning and Development(2008); United Nations(2006)
U.S. Europe China Japan
13
1950~70
Period
1980~2010
Period
2010
Period
Childhood Adulthood Elder
WWII Baby Boom: 1946~1964 U.S births increased rapidly Aging Boom: Baby boomers start to enter age of 65
Global Population of Children vs. Elders (%)
Under 5
It is estimated global population age over 65 will surpass age under 5 after 2020 and the difference will continue to grow.
Market of Aging Population
*Source: Franklin Templeton(2016); United States Census Bureau (2016); United Nations(2013)
Over65
Developed Countries
with Subcontract Manufacturing Focus
(ODM/OEM)
Emerging Countries
with Self-Branding Focus
(OBM)
US Japan Germany China Taiwan
Ove
rall In
de
x
Population (Million) 319 127 81 1364 23
Age
(0~14:15~64:65up) 19 : 67 : 14 13 : 61 : 26 13 : 66 : 21 17:74:9 13 : 74 : 13
Birth Rate:Death Rate 13 : 8 8 : 10 9 : 11 12 : 7 10 : 10
Fertility Rate 1.9 1.4 1.4 1.6 1.1
Life Expectancy at Birth 79 84 81 76 80
2014 GDP (Billion USD) 17,419 4,601 3,868 10,354 530
GDP per Capita(USD) 54,630 36,194 47,774 7,590 22,648
GDP Growth Rate 2.4% -0.1% 1.6% 7.3% 3.5%
Me
dic
al In
du
stry
Ind
ex
Health Expenditure per
Capita(USD) 9,403 3,703 5,477 420 2,479
Change of Health
Expenditure per Capita
(2011 ~ 2014)
3 ~ 5%
Steady
-17 ~ 2%
Fluctuated
-5% ~ 7%
Fluctuated
14 ~ 18%
Fast Growing
2 ~ 3%
Steady
Health Expenditure / GDP
(%) 17.1 10.2 11.3 5.5 6.6
Hospital Beds per 1000
persons (unit) 2.9 13.7 8.2 3.8 6.4
14
Overall Index of Geographic Areas
Source: World Bank(2014); IMF International Financial Statistics (IFS 2014); AmCham TW
15
Population Structure of Geographic Areas
Due to the worldwide low birth rates, the
population structure is aging
at a faster rate. Population of age above 65
Country Percentage of population above age 65 Period of time expected
7% 10% 14% 20% 30% 7%→14% 10%→20% 20%→30%
Taiwan 1993 2005 2017 2025 2040 24 20 15
Singapore 2000 2010 2016 2023 2034 16 13 11
South Korea 2000 2007 2017 2026 2040 17 19 14
Japan 1970 1985 1994 2005 2024 24 20 19
China 2001 2016 2026 2036 - 25 20 -
United States 1942 1972 2015 2034 - 73 62 -
Germany 1932 1952 1972 2009 2036 40 57 27
UK 1929 1946 1975 2026 - 46 80 -
Italy 1927 1966 1988 2007 2036 61 41 29
Switzerland 1887 1948 1972 2015 - 85 67 -
France 1864 1943 1979 2020 - 115 77 -
Source: 1. Council for Economic Planning and Development
2.United Nations, World Population Prospects:The 2006 Revision.
16
Our Major Exporting Regions
Taiwan 17.8%
Other Asia 10.8%
China 11.0%
North America
9.6%
Other Europe
8.2%
Germany 5.8%
Middle East & Others 7.2%
Latin America
4.7%
PAHSCO 2014
Japan
24.9%
Taiwan 18.5%
Other Asia 12.5%
China 12.0%
North America
9.1%
Other Europe
9.3%
Germany 7.1%
Middle East & Others 6.2%
Latin America
4.4%
PAHSCO 2015
Japan
20.9%
17
Our Major Exporting Regions
Taiwan 19.7%
China 15.7%
Other Asia 12.7%
North America
7.2%
Latin America
4.0%
Germany 6.1%
Other Europe
8.8%
Middle East & Others 7.0%
PAHSCO 2Q2015
Japan
18.8%
Taiwan 16.6%
China 11.3%
Other Asia 12.1%
North America
8.4%
Latin America
5.2%
Germany 5.7%
Other Europe 10.1%
Middle East & Others 6.4%
PAHSCO 2Q2016
Japan
24.2%
18
85% 90% 95% 100%
2010
2011
2012
2013
2014
2015
2Q2015
2Q2016
90.5%
91.0%
90.5%
90.9%
90.90%
90.40%
90.6%
94.1%
5.00%
5.9%
6.9%
7.0%
7.00%
8.50%
9.0%
5.4%
2.9%
3.1%
2.6%
2.1%
2.10%
1.10%
0.4%
0.5%
Medical Device Medical Equipment Piping System
Percentage of Product Categories
19
Tubes, 27%
CSS, 24%
Bags, 13%
Others,
22%
Wound
Drainage
System, 9%
Bottles, 3%
Respiratory
, 2%
Disposable Medical Device
Closed Suction System (CSS) Sales Revenue:363 Million(NTD) % of Product TR: 24% (2nd )
Tubes Sales Revenue:412 Million(NTD) % of Product TR: 27% (1st )
Bags Sales Revenue:189 Million(NTD) % of Product TR: 13% (3rd)
Wound Drainage System Sales Revenue:129 Million(NTD) % of Product TR: 9% (4th)
PAHSCO 2014
20
Tubes, 26%
CSS, 25%
Bags, 12%
Others,
24%
Wound
Drainage
System, 8%
Bottles, 3%
Respiratory
, 2%
Disposable Medical Device
Closed Suction System (CSS) Sales Revenue:399 Million(NTD) % of Product TR: 25% (2nd )
Tubes Sales Revenue:418 Million(NTD) % of Product TR: 26% (1st )
Bags Sales Revenue:193 Million(NTD) % of Product TR: 12% (3rd)
Wound Drainage System Sales Revenue:130 Million(NTD) % of Product TR: 8% (4th)
PAHSCO 2015
21
Tubes, 28%
CSS, 22%
Bags, 13%
Others,
24%
Wound
Drainage
System, 7%
Bottles, 3%
Respiratory
, 3%
Disposable Medical Device
Closed Suction System (CSS) Sales Revenue:158 Million(NTD) % of Product TR: 22% (2nd )
Tubes Sales Revenue:198 Million(NTD) % of Product TR: 28% (1st )
Bags Sales Revenue:91 Million(NTD) % of Product TR: 13% (3rd)
PAHSCO 2Q2015
Wound Drainage System Sales Revenue:51 Million(NTD) % of Product TR: 7% (4th)
22
Tubes, 25%
CSS, 27%
Bags, 11%
Others,
23%
Wound
Drainage
System,
10%
Bottles, 2%
Respiratory
, 2%
Disposable Medical Device
Tubes Sales Revenue:229 Million(NTD) % of Product TR: 25% (2nd )
Closed Suction System (CSS) Sales Revenue:244 Million(NTD) % of Product TR: 27% (1st )
Bags Sales Revenue:102 Million(NTD) % of Product TR: 11% (3rd)
PAHSCO 2Q2016
Wound Drainage System Sales Revenue:91 Million(NTD) % of Product TR: 10% (4th)
23
Sales Distribution (By Domestic & Export)
Domestic 17.8%
Export 82.2%
PAHSCO 2014
PAHSCO 2Q2015
Domestic 20.0%
Export 80.0%
PAHSCO 2Q2016
Domestic 17.0%
Export 83.0%
1980 2002 2015
Export 0% 5% 82%
Domestic 100% 95% 18%
24
Sales Distribution (By Customer Type)
OBM 47.6%
OEM/ODM
52.4% OBM
50.8%
OEM/ODM 49.2%
PAHSCO 2014 PAHSCO 2015
PAHSCO 2Q2015
OBM 59.8%
OEM/ODM 40.2%
PAHSCO 2Q2016
OBM 51.2%
OEM/ODM 48.8%
25
Sales Distribution (By Currency Type)
JPY
16%
TWD
20%
CNY
16%
Euro
5%
PAHSCO 2Q2015
USD
44%
JPY
17%
TWD
17%
CNY
11%
Euro
5%
PAHSCO 2Q2016
USD
50%
JPY
22%
TWD
18%
CNY
11%
Euro
5%
PAHSCO 2014
USD
44% JPY
16%
TWD
19%
CNY
12%
Euro
5%
PAHSCO 2015
USD
48%
26
Sales by Quarter
Unit: Thousand (NTD)
YEAR 2008 2009 2010 2011 2012 2013 2014 2015 2016
Q1 222,680 246,505 299,794 325,890 342,607 357,542 371,812 363,487 452,010
Q2 221,649 282,752 319,461 372,298 341,626 382,503 362,975 353,704 452,427
Q3 240,016 294,085 310,737 342,243 369,016 351,901 376,479 439,502
Q4 276,562 311,086 318,310 303,188 385,459 351.950 395,398 464,871
Total 960,906 1,134,428 1,248,302 1,343,619 1,438,708 1,443,896 1,506,664 1,621,564 904,437
Growth 15.4% 18.1% 10.0% 7.7% 7.1% 0.4% 4.4% 7.6% 26.1%
Gross Margin
33.3% 39.4% 41.1% 38.7% 39.2% 37.5% 36.1% 36.9% 38.9%
27
Financial Information
ITEM 2008 2009 2010 2011 2012 2013 2014 2015
2Q
2015
2Q
2016
EPS 3.53 4.24 5.44 5.39 4.77 4.88 4.95 5.32 1.74 2.94
ROE % 22.23 22.71 27.85 22.62 20.28 19.49 18.55 18.18 6.33 9.54
ROA % 14.00 16.15 22.02 18.93 16.75 16.06 15.33 14.32 4.85 6.81
Net Profit
Margin 17.60 20.69 27.27 24.06 21.90 22.29 21.70 21.66 16.06 21.49
Net Cash
per Share 7.20 8.00 9.84 10.44 12.40 12.64 11.82 6.81 9.09 4.56
* Ignore the evaluation loss of financial liabilities
*2010Pay-out: $3 Cash Dividend and $1.12 Stock Dividend presented at the Shareholders’ Meeting.
*2011Pay-out: $3 Cash Dividend and $1.00Stock Dividend presented at the Shareholders’ Meeting.
*2012Pay-out: $4 Cash Dividend presented at the Shareholders’ Meeting .
*2013Pay-out: $2.5 Cash Dividend presented at the Shareholders’ Meeting.
*2014Pay-out: $2.5 Cash Dividend presented at the Shareholders’ Meeting.
*2015Pay-out: $2.5 Cash Dividend presented at the Shareholders’ Meeting.
28
Medical Device Market Size in China
Market size Market growth rate Unit: Million (USD)
Source: BMI Espicom(2015); 工研院IEK(2015)
CAGR 14.8%
29
Revenue
(NTD) 2008 2009 2010 2011 2012 2013 2014 2015 2Q15 2Q16
Total 9.6 11.3 12.5 13.4 14.4 14.4 15.1 16.2 7.2 9.0
China 0.49 0.73 0.83 1.15 1.30 1.43 1.65 1.94 1.13 1.02
% 5.1 % 6.5 % 6.7 % 8.5 % 9.0 % 9.9% 11.0% 12% 15.7% 11.3%
0.49 0.73 0.83
1.15 1.30
1.43 1.65
1.94
1.13 1.02
2008 2009 2010 2011 2012 2013 2014 2015 2Q20152Q2016
Unit: Thousand (NTD)
14% -9.6%
50% 13%
38%
Our Sales in China
10%
yoy
15%
30
Areas covered
Total
Areas *31 Provinces
+ Taiwan
+ Hong Kong
+ Macau
34
2014
Covered *T1: 11
*T1 + T2: 150
20
2015
Covered *T1: 13
*T1 + T2: 180
23
2016
Target
Areas
6 provinces
• Sichuan • Sandong • Fujian • Hubei • Hunan • Chongqing
Our Distribution in China
31
Thank you
for your attention & patience!
*For your information, PAHSCO presentation will be updated quarterly on the official website: http://www.pahsco.com.tw/investment-23